Screener
Heron Therapeutics HRTX Q1 2026 earnings
Reported May 11, 2026 · Before market open
Revenue$34.7MMiss by $2.0M
EPS-$0.04Miss by $0.01
Revenue estimate$36.7M
EPS estimate-$0.03
Next report
Nov 3, 2026 (in 2 months)Revenue estimate$37.5M
EPS estimate-$0.03
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Heron Therapeutics report Q1 2026 earnings?
- Heron Therapeutics (HRTX) reported Q1 2026 earnings on May 11, 2026 before market open.
- What were Heron Therapeutics's Q1 2026 revenue and EPS?
- Heron Therapeutics reported revenue of $34.7M and eps of $-0.04 for Q1 2026.
- Did Heron Therapeutics beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $36.7M by $2.0M. EPS missed the consensus estimate of $-0.03 by $0.01.
- How did Heron Therapeutics's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 10.8% from $38.9M a year earlier.
- Where can I find Heron Therapeutics's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-215752) and the 10-Q periodic report (0001193125-26-215755) directly on SEC EDGAR. The filing index links above go to sec.gov.
